From bench to the bedside: understanding the genetic changes in AML
Overcoming the issues with clinical trial recruitment
We know that MRD is relevant, what next?
The importance of the collaboration of the solid and liquid tumor communities
Big data for HemOnc in Europe: HARMONY
Jesús María Hernández Rivas